Home Featured Page 259

Featured

Latest

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic...

IntelGenx Announces Shareholder Approval of atai Investment

Exploring Oregon’s Measure 110 and The Future of Drug Policy Reform

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of...

Henrik Dahl’s Review of Pickard’s ‘The Rose of Paracelsus: On Secrets...

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health...

PT243 – Dr. Fernando Espi Forcen and Dr. Franklin King of...

CB Therapeutics Closes on Oversubscribed Series A

Psychedelic Therapy for Borderline Personality Disorder?

Psychedelics Today’s 5th Birthday Party

1...258259260...306 Page 259 of 306

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic...

IntelGenx Announces Shareholder Approval of atai Investment

Exploring Oregon’s Measure 110 and The Future of Drug Policy Reform

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of...

Henrik Dahl’s Review of Pickard’s ‘The Rose of Paracelsus: On Secrets...

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health...

PT243 – Dr. Fernando Espi Forcen and Dr. Franklin King of...

CB Therapeutics Closes on Oversubscribed Series A

Psychedelic Therapy for Borderline Personality Disorder?

Psychedelics Today’s 5th Birthday Party

EDITOR PICKS

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY